Commentary on Arunogiriet al. (2020): Findings from surveillance of patterns of drug use and related harms need careful interpretation, promotion and response

Gamma-hydroxybutyrate (GHB) is used by few people in Australia, yet is associated with significant harm. Although there are few GHB-related fatalities, recommended management of GHB overdose requires a significant amount of resources in the emergency response. Arunogiri et al. 1 document a large increase in the incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Victoria, Australia during the period 2012–17, followed by a...